Thank you for your interest in Cerebain Biotech Corp. The company appreciates your continued support.
The company continues to work diligently to get current on all its public filings with the SEC and intends to make those filings in the future.
Until further notice, the company will no longer respond to inquiries via email and will make all announcements via press releases and regulatory filings. Thank you.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.